Skip to content

Verification of the antiobesity effect of a plant extractIngredient G-PX

Verification of the antiobesity effect of a plant extractIngredient G-PX - Verification of the antiobesity effect of a plant extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021529
Enrollment
100
Registered
2016-03-18
Start date
2016-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

once a day for 12weeks Placebo capsule 10mg once a day for 12weeks

Sponsors

Ezaki Glico Co.,Ltd.,Institute of Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Men and women aged >= 20years (2)Those with BMI in the range>=25to<30 (3)Those who can visit the specified institution on the scheduled day of visit (4)Those who adequately understand the objective and details of this study, and give written informed consent

Exclusion criteria

Exclusion criteria: (1)Those who are receiving treatment at the time of participation in the study (2)Pregnant (or possibly pregnant) or lactating women (3)Those who have donated blood components or 200 mL of whole blood within 4 weeks prior to the consumption of the test food (4)Those who have donated 400 mL of whole blood within 16 weeks prior to the consumption of the test food (5)Those who have had >1,000 mL of blood collected within 48 weeks prior to the consumption of the test food (6)Those who are participating in another trial or study (7)Those who meet any of the following criteria: i.Those with heart, liver, or kidney disease (including complications of other diseases) ii.Those with a history of cardiovascular disease iii.Those with diabetes mellitus iv.Those who are being treated for or with a history of serious diseases including cancer and asthma (8)Those with a history of major surgery in the gastrointestinal regions, including gastrectomy, gastrointestinal suture, and intestinal resection (9)Those with severe food allergy (10)Those who routinely take supplements that contain the same components as the test food (11)Those judged inadequate to enroll in the study at the discretion of the principal investigator or subinvestigator

Design outcomes

Primary

MeasureTime frame
Change in the visceral fat area between before consumption of the test food and at the end of consumption

Countries

Japan

Contacts

Public ContactRyou Kakutani

Ezaki Glico Co., Ltd. Institute of Helth Sciences

kakutani-ryou@glico.co.jp06-6477-8362

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026